Clinical Trials in Houston

Showing 13001-13020 of 17,885 trials

A Phase II Trial of Cetuximab and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer

NCT00409565

The purpose of this study is to determine if the combination of two new drugs, cetuximab (Erbitux) and bevacizumab (Avastin) can increase the effectiveness of treatment for head and neck cancer. Cetuximab has recently been approved by the FDA for head and neck cancer (that is locally or regionally advanced) when used in combination with radiation therapy. Cetuximab is also approved by the FDA for the treatment of colorectal cancer

Head and Neck CancerSquamous Cell Carcinoma

National Cancer Institute (NCI)48 participantsStarted Sep 2006

Ann Arbor, Michigan, United States • Cleveland, Ohio, United States • Pittsburgh, Pennsylvania, United States +1 more locations

COMPLETED< 1 mile

Oral Margin Spectroscopy Detection Using Optical Spectroscopy

NCT00439205

The goal of this clinical research study is to evaluate an imaging technology that may help clinicians see how far an area of pre-cancerous or cancerous tissue extends in the mouth.

Oral Tumors

M.D. Anderson Cancer Center58 participantsStarted Feb 2007

Houston, Texas, United States

COMPLETEDPhase 1< 1 mile

A Safety Study of SGN-CD19A for B-Cell Lymphoma

NCT01786135

This is a phase 1, open-label, dose-escalation, multicenter study to evaluate the safety and tolerability of SGN-CD19A in patients with relapsed or refractory B-lineage non-Hodgkin lymphoma (B-NHL)

Burkitt LymphomaLymphoma, FollicularLymphoma, Large B-Cell, Diffuse+2 more

Seagen Inc.64 participantsStarted Feb 2013

Birmingham, Alabama, United States • Duarte, California, United States • Stanford, California, United States +3 more locations

A Phase II Trial of Cetuximab and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck Cancer

Oral Margin Spectroscopy Detection Using Optical Spectroscopy

A Safety Study of SGN-CD19A for B-Cell Lymphoma

Find Trials by Condition in Houston

Improving Teamwork for Neonatal Resuscitation

CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma

Rollover Trial for Placebo Subjects Previously Enrolled Into GEN-003-002 Study

A Phase I Study to Evaluate the Safety, Tolerability and Efficacy of MEDI4736 (Durvalumab) With Tremelimumab in Head and Neck Cancer

A Research Study To Assess The Effectiveness And Safety Of Different Doses Of Oral PF-00489791 In The Treatment Of Adult Patients With Pulmonary Arterial Hypertension

Comparison of DISCOVER™ Artificial Cervical Disc and ACDF for Treatment of Cervical DDD (IDE Study)

Colorectal Cancer Treated With Adjuvant Regorafenib Versus Placebo After Curative Treatment of Liver Metastases in a Randomized, Double-blind, Placebo-Controlled Phase-III STudy

Study of a New Thermo Stable Formulation of Epoprostenol Sodium to Treat Pulmonary Arterial Hypertension (PAH)

A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD)

NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation

The Treatment of Glabellar Frown Lines

The Vascutek AnacondaTM Stent Graft System Phase II IDE Study

Cosmesis, Patient Satisfaction and Quality of Life After da Vinci Single Site and Multiport Laparoscopic Cholecystectomy

Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)

A Study in Type 2 Diabetic Subjects on Stable Metformin Therapy to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Co-administering Single and Multiple Oral Doses of GSK1292263

Efficacy and Safety Study of ABP 215 Compared With Bevacizumab in Patients With Advanced Non-Small Cell Lung Cancer

Transversus Abdominis Plane (TAP) Block for Cesarean Section